spacer
spacer

PDBsum entry 6ugr

Go to PDB code: 
protein ligands metals links
Lyase/lyase inhibitor PDB id
6ugr

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
257 a.a.
Ligands
Q71
Metals
_ZN
Waters ×216
PDB id:
6ugr
Name: Lyase/lyase inhibitor
Title: Human carbonic anhydrase 2 complexed with sb4-208
Structure: Carbonic anhydrase 2. Chain: a. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.31Å     R-factor:   0.152     R-free:   0.165
Authors: A.B.Murray,C.L.Lomelino,R.Mckenna
Key ref: S.Bua et al. (2020). "A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII. J Med Chem, 63, 321-333. PubMed id: 31794211 DOI: 10.1021/acs.jmedchem.9b01669
Date:
26-Sep-19     Release date:   18-Dec-19    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00918  (CAH2_HUMAN) -  Carbonic anhydrase 2 from Homo sapiens
Seq:
Struc:
260 a.a.
257 a.a.
Key:    PfamA domain  Secondary structure

 Enzyme reactions 
   Enzyme class: E.C.4.2.1.1  - carbonic anhydrase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: hydrogencarbonate + H+ = CO2 + H2O
hydrogencarbonate
+ H(+)
= CO2
+ H2O
      Cofactor: Zn(2+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1021/acs.jmedchem.9b01669 J Med Chem 63:321-333 (2020)
PubMed id: 31794211  
 
 
"A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII.
S.Bua, C.Lomelino, A.B.Murray, S.M.Osman, Z.A.ALOthman, M.Bozdag, H.A.Abdel-Aziz, W.M.Eldehna, R.McKenna, A.Nocentini, C.T.Supuran.
 
  ABSTRACT  
 
The sweeteners saccharin (SAC) and acesulfame K (ACE) recently entered the topic of anticancer human carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, as they showed to selectively inhibit the tumor-associated CAs IX/XII over ubiquitous CAs. A drug design strategy is here reported, which took SAC and ACE as leads and produced a series of 2H-benzo[e][1,2,4]thiadiazin-3(4H)-one-1,1-dioxides (BTD). Many derivatives showed greater potency (
 

 

spacer

spacer